Thermo Fisher Scientific (TMO) Stock: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$663.04
0.80 (0.12%)
▲
5d:
+0.98%
30d:
+8.05%
90d:
+23.87%
HOLD
MODERATE Confidence
Analysis Updated: Oct 13, 2026 12:00 AM ET
Earnings: Oct 21, 2026
6d
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TMO trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: TMO trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$786.65
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$488.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $663.04, which is considered slightly high relative to its 30-day fair value range of $625.71 to $674.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 24.0) compared to its historical average (20.5). At these levels, the market is pricing in 5.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TMO is in a strong uptrend. Immediate support is located at $635.32, while resistance sits at $694.33.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TMO is in a strong uptrend. Immediate support is located at $635.32, while resistance sits at $694.33.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$625.71 -
$674.73
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.5%
Protect Your Profits
Holding TMO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($680.44)
- NEUTRAL: Trading at premium valuation - market expects 5.5% growth which is achievable
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$625.71 -
$674.73
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$635.32
Resistance Level
$694.33
Current Trend
Strong Uptrend
Technical data as of
Oct 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.04
Wall Street Target
$680.44
(+2.6%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
9.4%
Profit Margin
15.0%
Valuation Premium vs History
+5.5% premium
PE vs Historical
24.0 vs 20.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.5%
(market-implied from PE analysis)
1-Year Target
$699.51
(+6%)
2-Year Target
$737.98
(+11%)
3-Year Target
$778.57
(+17%)
3-Yr Target (if PE normalizes)
(PE: 24→21)
PE COMPRESSION
$663.82
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.0, Growth: 9.7%)
$875.58
(+32%)
Base:
(SPY PE: 19.9, Growth: 9.7%)
$723.23
(+9%)
Bear:
(PE: 16.9, Growth: 9.7%)
$614.74
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 35.87 | Current EPS (TTM): $18.46
Bull Case
$1088.22
(+64%)
Analyst growth 49.4%, PE expands to 39.5
Base Case
$989.29
(+49%)
Market implied 49.4%, PE stable at 35.9
Bear Case
$450.32
(-32%)
Severe decline -20.0%, PE contracts to 30.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 14, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$241 | 54 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$200 | 38 SELL |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
22 analysts |
$295 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$380 | 48 HOLD |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
